As shown in our previous study in NSCLC cells, the metabolic switch from glycolysis to oxidative phosphorylation is not compensatory but the result of the fine tuning of the AKT and ERK1/2 pathways in NSCLC cells [16]. This evidence concerns the gene MAPK3 and non-small cell lung carcinoma.